血友病A&B治療機器の世界市場動向・分析2018-2025

【英語タイトル】Global Hemophillia A and B Therapeutics Materials Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D04721)・商品コード:QYR8D04721
・発行会社(調査会社):QYResearch
・発行日:2018年12月6日
・ページ数:119
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、血友病A&B治療機器の世界市場について調査・分析し、種類別には、デスモプレシン、第VIII因子製剤 、ノナコグアルファ、その他 に、用途別には、デンタルクリニック、病院、外来外科センター に区分してまとめました。調査対象企業は、Arsia therapeutics、Spark Therapeutics, Inc.、Alnylam Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.等です。

・レポートの概要
・グローバル成長トレンド
・血友病A&B治療機器の世界市場規模
・血友病A&B治療機器の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別血友病A&B治療機器の価格動向
・血友病A&B治療機器の種類別市場規模(デスモプレシン、第VIII因子製剤 、ノナコグアルファ、その他 )
・血友病A&B治療機器の用途別市場規模(デンタルクリニック、病院、外来外科センター )
・血友病A&B治療機器の北米市場(アメリカ、カナダ、メキシコ)
・血友病A&B治療機器のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・血友病A&B治療機器のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・血友病A&B治療機器の中南米市場(ブラジル等)
・血友病A&B治療機器の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Arsia therapeutics、Spark Therapeutics, Inc.、Alnylam Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・血友病A&B治療機器の市場規模予測
・血友病A&B治療機器の種類別市場予測2018-2025(デスモプレシン、第VIII因子製剤 、ノナコグアルファ、その他 )
・血友病A&B治療機器の用途別市場予測2018-2025(デンタルクリニック、病院、外来外科センター )
・血友病A&B治療機器の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・血友病A&B治療機器のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・血友病A&B治療機器のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・血友病A&B治療機器の中南米市場予測2018-2025(ブラジル等)
・血友病A&B治療機器の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Hemophilia is a rare, inherited disorder in which blood doesn’t clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a protein required for blood clotting to occur normally. Novel treatments for people suffering from hemophilia and other different bleeding problems has evolved over the past. Hemostasis requires a specific missing plasma protein to prevent unnecessary bleeding, they are named as different factors in the blood. Furthermore, these proteins are contained in concentrate products of lyophilized factor. The analysis in the report describes the purity and viral safety issues for most of the coagulation products currently available along with the market potential. A prompt treatment is required for therapeutic management of bleeding disorders during the bleeding episodes to minimize complications ascending from accumulation of blood in joint spaces that may result in compartment syndrome and have its own complication in health of an individual. There are number of treatment regimens available in the form of non-complicated and complicated bleeding episodes.
The Hemophillia A and B Therapeutics Materials market was valued at xx Million US$ in 2017 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Hemophillia A and B Therapeutics Materials.

This study focuses on the production side and consumption side of Hemophillia A and B Therapeutics Materials, presents the global Hemophillia A and B Therapeutics Materials market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
In terms of production side, this report researches the Hemophillia A and B Therapeutics Materials capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Hemophillia A and B Therapeutics Materials by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.
Arsia therapeutics
Spark Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc.
Sangamo Therapeutics, Inc.

Market Segment by Product Type
Desmopressin
Octocogalfa
Nonacogalfa
Others 

Market Segment by Application
Dental Clinics
Hospitals
Ambulatory Surgical Centers

Key Regions split in this report:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa

The study objectives are:
To analyze and research the global Hemophillia A and B Therapeutics Materials status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Hemophillia A and B Therapeutics Materials manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hemophillia A and B Therapeutics Materials are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Hemophillia A and B Therapeutics Materials Market Size Growth Rate by Type
1.3.2 Desmopressin
1.3.3 Octocogalfa
1.3.4 Nonacogalfa
1.3.5 Others 
1.4 Market Segment by Application
1.4.1 Global Hemophillia A and B Therapeutics Materials Market Share by Application (2018-2025)
1.4.2 Dental Clinics
1.4.3 Hospitals
1.4.4 Ambulatory Surgical Centers
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Hemophillia A and B Therapeutics Materials Production Value 2013-2025
2.1.2 Global Hemophillia A and B Therapeutics Materials Production 2013-2025
2.1.3 Global Hemophillia A and B Therapeutics Materials Capacity 2013-2025
2.1.4 Global Hemophillia A and B Therapeutics Materials Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2018-2025
2.2.1 Global Hemophillia A and B Therapeutics Materials Market Size CAGR of Key Regions
2.2.2 Global Hemophillia A and B Therapeutics Materials Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Hemophillia A and B Therapeutics Materials Capacity by Manufacturers
3.1.2 Global Hemophillia A and B Therapeutics Materials Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Hemophillia A and B Therapeutics Materials Revenue by Manufacturers (2013-2018)
3.2.2 Hemophillia A and B Therapeutics Materials Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Hemophillia A and B Therapeutics Materials Market Concentration Ratio (CR5 and HHI)
3.3 Hemophillia A and B Therapeutics Materials Price by Manufacturers
3.4 Key Manufacturers Hemophillia A and B Therapeutics Materials Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Hemophillia A and B Therapeutics Materials Market
3.6 Key Manufacturers Hemophillia A and B Therapeutics Materials Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Desmopressin Production and Production Value (2013-2018)
4.1.2 Octocogalfa Production and Production Value (2013-2018)
4.1.3 Nonacogalfa Production and Production Value (2013-2018)
4.1.4 Others  Production and Production Value (2013-2018)
4.2 Global Hemophillia A and B Therapeutics Materials Production Market Share by Type
4.3 Global Hemophillia A and B Therapeutics Materials Production Value Market Share by Type
4.4 Hemophillia A and B Therapeutics Materials Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Hemophillia A and B Therapeutics Materials Consumption by Application

6 Production by Regions
6.1 Global Hemophillia A and B Therapeutics Materials Production (History Data) by Regions 2013-2018
6.2 Global Hemophillia A and B Therapeutics Materials Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Hemophillia A and B Therapeutics Materials Production Growth Rate 2013-2018
6.3.2 United States Hemophillia A and B Therapeutics Materials Production Value Growth Rate 2013-2018
6.3.3 Key Players in United States
6.3.4 United States Hemophillia A and B Therapeutics Materials Import & Export
6.4 Europe
6.4.1 Europe Hemophillia A and B Therapeutics Materials Production Growth Rate 2013-2018
6.4.2 Europe Hemophillia A and B Therapeutics Materials Production Value Growth Rate 2013-2018
6.4.3 Key Players in Europe
6.4.4 Europe Hemophillia A and B Therapeutics Materials Import & Export
6.5 China
6.5.3 Key Players in China
6.5.2 China Hemophillia A and B Therapeutics Materials Production Value Growth Rate 2013-2018
6.5.3 Key Players in China
6.5.4 China Hemophillia A and B Therapeutics Materials Import & Export
6.6 Japan
6.6.1 Japan Hemophillia A and B Therapeutics Materials Production Growth Rate 2013-2018
6.6.2 Japan Hemophillia A and B Therapeutics Materials Production Value Growth Rate 2013-2018
6.6.3 Key Players in Japan
6.6.4 Japan Hemophillia A and B Therapeutics Materials Import & Export
6.7 Other Regions
6.7.1 South Korea
6.7.2 India
6.7.3 Southeast Asia

7 Hemophillia A and B Therapeutics Materials Consumption by Regions
7.1 Global Hemophillia A and B Therapeutics Materials Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Hemophillia A and B Therapeutics Materials Consumption by Type
7.2.2 North America Hemophillia A and B Therapeutics Materials Consumption by Application
7.2.3 North America Hemophillia A and B Therapeutics Materials Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Hemophillia A and B Therapeutics Materials Consumption by Type
7.3.2 Europe Hemophillia A and B Therapeutics Materials Consumption by Application
7.3.3 Europe Hemophillia A and B Therapeutics Materials Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Hemophillia A and B Therapeutics Materials Consumption by Type
7.4.2 Asia Pacific Hemophillia A and B Therapeutics Materials Consumption by Application
7.4.3 Asia Pacific Hemophillia A and B Therapeutics Materials Consumption by Countries
7.4.4 China
7.4.5 Japan
7.4.6 Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Hemophillia A and B Therapeutics Materials Consumption by Type
7.5.2 Central & South America Hemophillia A and B Therapeutics Materials Consumption by Application
7.5.3 Central & South America Hemophillia A and B Therapeutics Materials Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption by Type
7.6.2 Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption by Application

8 Company Profiles
8.1 Arsia therapeutics
8.1.1 Arsia therapeutics Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Hemophillia A and B Therapeutics Materials
8.1.4 Hemophillia A and B Therapeutics Materials Product Introduction
8.1.5 Arsia therapeutics Recent Development
8.2 Spark Therapeutics, Inc.
8.2.1 Spark Therapeutics, Inc. Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Hemophillia A and B Therapeutics Materials
8.2.4 Hemophillia A and B Therapeutics Materials Product Introduction
8.2.5 Spark Therapeutics, Inc. Recent Development
8.3 Alnylam Pharmaceuticals, Inc.
8.3.1 Alnylam Pharmaceuticals, Inc. Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Hemophillia A and B Therapeutics Materials
8.3.4 Hemophillia A and B Therapeutics Materials Product Introduction
8.3.5 Alnylam Pharmaceuticals, Inc. Recent Development
8.4 Sangamo Therapeutics, Inc.
8.4.1 Sangamo Therapeutics, Inc. Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Hemophillia A and B Therapeutics Materials
8.4.4 Hemophillia A and B Therapeutics Materials Product Introduction
8.4.5 Sangamo Therapeutics, Inc. Recent Development

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Hemophillia A and B Therapeutics Materials Capacity, Production Forecast 2018-2025
9.1.2 Global Hemophillia A and B Therapeutics Materials Production Value Forecast 2018-2025
9.2 Hemophillia A and B Therapeutics Materials Production and Production Value Forecast by Regions
9.2.1 Global Hemophillia A and B Therapeutics Materials Production Value Forecast by Regions
9.2.2 Global Hemophillia A and B Therapeutics Materials Production Forecast by Regions
9.3 Hemophillia A and B Therapeutics Materials Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.3.5 Other Regions
9.4 Forecast by Type
9.4.1 Global Hemophillia A and B Therapeutics Materials Production Forecast by Type
9.4.2 Global Hemophillia A and B Therapeutics Materials Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Hemophillia A and B Therapeutics Materials Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Hemophillia A and B Therapeutics Materials Consumption Forecast by Countries 2018-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Hemophillia A and B Therapeutics Materials Consumption Forecast by Countries 2018-2025
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Hemophillia A and B Therapeutics Materials Consumption Forecast by Countries 2018-2025
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Hemophillia A and B Therapeutics Materials Consumption Forecast by Country 2018-2025
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption Forecast by Countries 2018-2025
10.7.2 Middle East and Africa
10.7.3 GCC Countries
10.7.4 Egypt
10.7.5 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Hemophillia A and B Therapeutics Materials Sales Channels
11.2.2 Hemophillia A and B Therapeutics Materials Distributors
11.3 Hemophillia A and B Therapeutics Materials Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

List of Tables and Figures

Figure Hemophillia A and B Therapeutics Materials Product Picture
Table Hemophillia A and B Therapeutics Materials Key Market Segments
Table Major Manufacturers Hemophillia A and B Therapeutics Materials Covered in This Report
Table Global Hemophillia A and B Therapeutics Materials Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Hemophillia A and B Therapeutics Materials Sales Market Shar by Type 2013-2025
Figure Desmopressin Figures
Table Major Manufacturers of Desmopressin
Figure Octocogalfa Figures
Table Major Manufacturers of Octocogalfa
Figure Nonacogalfa Figures
Table Major Manufacturers of Nonacogalfa
Figure Others  Figures
Table Major Manufacturers of Others 
Table Global Hemophillia A and B Therapeutics Materials Market Share by Application 2018-2025 (K Units)
Figure Dental Clinics Use Case
Figure Hospitals Use Case
Figure Ambulatory Surgical Centers Use Case
Figure Hemophillia A and B Therapeutics Materials Report Years Considered
Figure Global Hemophillia A and B Therapeutics Materials Production Value Growth Rate 2013-2025 (Million US$)
Figure Global Hemophillia A and B Therapeutics Materials Production 2013-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Capacity 2013-2025 (K Units)
Table Key Manufacturers Hemophillia A and B Therapeutics Materials Capacity (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Price 2013-2025 (USD/Unit)
Table Global Hemophillia A and B Therapeutics Materials Market Size of Key Regions (Million USD) & (K Units)
Table Global Hemophillia A and B Therapeutics Materials Growth Rate of Key Regions 2018-2025 (Million USD)
Table Global Hemophillia A and B Therapeutics Materials Market Share for of Regions 2018-2025 (K Units)
Table Market Top Trends
Table Global Hemophillia A and B Therapeutics Materials Capacity by Manufacturers (2013-2018) (K Units)
Table Global Hemophillia A and B Therapeutics Materials Capacity Market Share by Manufacturers (2013-2018)
Table Global Hemophillia A and B Therapeutics Materials Production by Manufacturers (2013-2018) (K Units)
Table Global Hemophillia A and B Therapeutics Materials Production Share by Manufacturers (2013-2018)
Figure Global Hemophillia A and B Therapeutics Materials Production Share by Manufacturers in 2017
Table Hemophillia A and B Therapeutics Materials Revenue by Manufacturers (2013-2018) (Million USD)
Table Hemophillia A and B Therapeutics Materials Revenue Share by Manufacturers (2013-2018)
Figure Hemophillia A and B Therapeutics Materials Value Share by Manufacturers in 2017
Table Global Hemophillia A and B Therapeutics Materials Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Hemophillia A and B Therapeutics Materials Price by Manufacturers 2013-2018 (USD/Unit)
Table Key Manufacturers Hemophillia A and B Therapeutics Materials Plants/Factories Distribution
Table Key Manufacturers Hemophillia A and B Therapeutics Materials Area Served
Table Date of Key Manufacturers Enter into Hemophillia A and B Therapeutics Materials Market
Table Key Manufacturers Hemophillia A and B Therapeutics Materials Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Desmopressin Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global Octocogalfa Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global Nonacogalfa Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global Others  Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global Hemophillia A and B Therapeutics Materials Production by Type (2013-2018) (K Units)
Table Global Hemophillia A and B Therapeutics Materials Production Share by Type (2013-2018)
Figure Global Hemophillia A and B Therapeutics Materials Production Market Share by Type (2013-2018)
Figure Global Hemophillia A and B Therapeutics Materials Production Market Share by Type in 2017
Table Global Hemophillia A and B Therapeutics Materials Production Value by Type (2013-2018) (Million US$)
Table Global Hemophillia A and B Therapeutics Materials Production Value Share by Type (2013-2018)
Figure Global Hemophillia A and B Therapeutics Materials Production Value Market Share by Type (2013-2018)
Figure Global Hemophillia A and B Therapeutics Materials Production Value Market Share by Type in 2017
Table Hemophillia A and B Therapeutics Materials Ex-factory Price by Type 2013-2018 (USD/Unit)
Table Global Hemophillia A and B Therapeutics Materials Consumption by Application (2013-2018) (K Units)
Table Global Hemophillia A and B Therapeutics Materials Consumption Share by Application (2013-2018)
Figure Global Consumption Hemophillia A and B Therapeutics Materials Market Share by Application (2013-2018)
Table Global Hemophillia A and B Therapeutics Materials Production by Regions 2013-2018 (K Units)
Table Global Hemophillia A and B Therapeutics Materials Production Market Share by Regions 2013-2018
Figure Global Hemophillia A and B Therapeutics Materials Production Market Share by Regions 2013-2018
Figure Global Hemophillia A and B Therapeutics Materials Production Market Share by Regions in 2017
Table Global Hemophillia A and B Therapeutics Materials Production Value by Regions 2013-2018 (Million USD)
Table Global Hemophillia A and B Therapeutics Materials Production Value Market Share by Regions 2013-2018
Figure Global Hemophillia A and B Therapeutics Materials Production Value Market Share by Regions 2013-2018
Figure Global Hemophillia A and B Therapeutics Materials Production Value Market Share by Regions in 2017
Table United States Hemophillia A and B Therapeutics Materials Production and Value 2013-2018 (K Units) & (Million USD)
Figure United States Hemophillia A and B Therapeutics Materials Production Growth Rate 2013-2018 (K Units)
Figure United States Hemophillia A and B Therapeutics Materials Production Value Growth Rate 2013-2018 (Million USD)
Table United States Hemophillia A and B Therapeutics Materials Import & Export (K Units)
Table Europe Hemophillia A and B Therapeutics Materials Production and Value 2013-2018 (K Units) & (Million USD)
Figure Europe Hemophillia A and B Therapeutics Materials Production Growth Rate 2013-2018 (K Units)
Figure Europe Hemophillia A and B Therapeutics Materials Production Value Growth Rate 2013-2018 (Million USD)
Table Europe Hemophillia A and B Therapeutics Materials Import & Export (K Units)
Table China Hemophillia A and B Therapeutics Materials Production and Value 2013-2018 (K Units) & (Million USD)
Figure China Hemophillia A and B Therapeutics Materials Production Growth Rate 2013-2018 (K Units)
Figure China Hemophillia A and B Therapeutics Materials Production Value Growth Rate 2013-2018 (Million USD)
Table China Hemophillia A and B Therapeutics Materials Import & Export (K Units)
Table Japan Hemophillia A and B Therapeutics Materials Production and Value 2013-2018 (K Units) & (Million USD)
Figure Japan Hemophillia A and B Therapeutics Materials Production Growth Rate 2013-2018 (K Units)
Figure Japan Hemophillia A and B Therapeutics Materials Production Value Growth Rate 2013-2018 (Million USD)
Table Japan Hemophillia A and B Therapeutics Materials Import & Export (K Units)
Table Global Hemophillia A and B Therapeutics Materials Consumption by Regions 2013-2018 (K Units)
Table Global Hemophillia A and B Therapeutics Materials Consumption Market Share by Regions 2013-2018
Figure Global Hemophillia A and B Therapeutics Materials Consumption Market Share by Regions 2013-2018
Figure Global Hemophillia A and B Therapeutics Materials Consumption Market Share by Regions in 2017
Figure North America Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Table North America Hemophillia A and B Therapeutics Materials Consumption by Type (2013-2018) (K Units)
Figure North America Hemophillia A and B Therapeutics Materials Consumption Market Share by Type in 2018
Table North America Hemophillia A and B Therapeutics Materials Consumption by Application (2013-2018) (K Units)
Figure North America Hemophillia A and B Therapeutics Materials Consumption Market Share by Application in 2018
Table North America Hemophillia A and B Therapeutics Materials Consumption by Countries (2013-2018) (K Units)
Figure North America Hemophillia A and B Therapeutics Materials Consumption Market Share by Countries in 2018
Figure United States Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Canada Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Mexico Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Europe Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Table Europe Hemophillia A and B Therapeutics Materials Consumption by Type (2013-2018) (K Units)
Figure Europe Hemophillia A and B Therapeutics Materials Consumption Market Share by Type in 2018
Table Europe Hemophillia A and B Therapeutics Materials Consumption by Application (2013-2018) (K Units)
Figure Europe Hemophillia A and B Therapeutics Materials Consumption Market Share by Application in 2018
Table Europe Hemophillia A and B Therapeutics Materials Consumption by Countries (2013-2018) (K Units)
Figure Europe Hemophillia A and B Therapeutics Materials Consumption Market Share by Countries in 2018
Figure Germany Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure France Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure UK Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Italy Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Russia Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Table Asia Pacific Hemophillia A and B Therapeutics Materials Consumption by Type (2013-2018) (K Units)
Figure Asia Pacific Hemophillia A and B Therapeutics Materials Consumption Market Share by Type in 2018
Table Asia Pacific Hemophillia A and B Therapeutics Materials Consumption by Application (2013-2018) (K Units)
Figure Asia Pacific Hemophillia A and B Therapeutics Materials Consumption Market Share by Application in 2018
Table Asia Pacific Hemophillia A and B Therapeutics Materials Consumption by Countries (2013-2018) (K Units)
Table Asia Pacific Hemophillia A and B Therapeutics Materials Consumption Market Share by Countries (2013-2018)
Figure China Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Japan Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Korea Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure India Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Australia Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Indonesia Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Thailand Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Malaysia Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Philippines Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Vietnam Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Central & South America Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Table Central & South America Hemophillia A and B Therapeutics Materials Consumption by Type (2013-2018) (K Units)
Figure Central & South America Hemophillia A and B Therapeutics Materials Consumption Market Share by Type in 2018
Table Central & South America Hemophillia A and B Therapeutics Materials Consumption by Application (2013-2018) (K Units)
Figure Central & South America Hemophillia A and B Therapeutics Materials Consumption Market Share by Application in 2018
Table Central & South America Hemophillia A and B Therapeutics Materials Consumption by Countries (2013-2018) (K Units)
Figure Central & South America Hemophillia A and B Therapeutics Materials Consumption Market Share by Countries
Figure Brazil Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption Growth Rate (2013-2018) (K Units)
Table Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption by Type (2013-2018) (K Units)
Figure 2017 Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption Market Share by Type
Table Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption by Application (2013-2018) (K Units)
Figure 2017 Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption Market Share by Application
Table Arsia therapeutics Company Details
Table Arsia therapeutics Description and Business Overview
Table Arsia therapeutics Hemophillia A and B Therapeutics Materials Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Arsia therapeutics Hemophillia A and B Therapeutics Materials Production Growth Rate (2013-2018)
Table Arsia therapeutics Hemophillia A and B Therapeutics Materials Production Market Share in Global Market
Table Arsia therapeutics Recent Development
Table Spark Therapeutics, Inc. Company Details
Table Spark Therapeutics, Inc. Description and Business Overview
Table Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Production Growth Rate (2013-2018)
Table Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Production Market Share in Global Market
Table Spark Therapeutics, Inc. Recent Development
Table Alnylam Pharmaceuticals, Inc. Company Details
Table Alnylam Pharmaceuticals, Inc. Description and Business Overview
Table Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Production Growth Rate (2013-2018)
Table Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Production Market Share in Global Market
Table Alnylam Pharmaceuticals, Inc. Recent Development
Table Sangamo Therapeutics, Inc. Company Details
Table Sangamo Therapeutics, Inc. Description and Business Overview
Table Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Production Growth Rate (2013-2018)
Table Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Production Market Share in Global Market
Table Sangamo Therapeutics, Inc. Recent Development
Table Global Hemophillia A and B Therapeutics Materials Capacity, Production Forecast 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Capacity Forecast 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Production Forecast 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Production Value Forecast 2018-2025 (Million US$)
Table Global Hemophillia A and B Therapeutics Materials Revenue Forecast 2018-2025 (Million US$)
Table Global Hemophillia A and B Therapeutics Materials Production Value Forecast by Regions 2018-2025 (Million US$)
Figure Global Hemophillia A and B Therapeutics Materials Production Value Forecast by Regions 2018-2025 (Million US$)
Figure Global Hemophillia A and B Therapeutics Materials Production Value Market Share Forecast by Regions 2018-2025
Table Global Hemophillia A and B Therapeutics Materials Production Forecast by Regions 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Production Forecast by Regions 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Production Market Share Forecast by Regions 2018-2025
Table United States Hemophillia A and B Therapeutics Materials Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure United States Hemophillia A and B Therapeutics Materials Production Forecast 2018-2025 (K Units)
Figure United States Hemophillia A and B Therapeutics Materials Revenue Forecast 2018-2025 (Million US$)
Table Europe Hemophillia A and B Therapeutics Materials Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure Europe Hemophillia A and B Therapeutics Materials Production Forecast 2018-2025 (K Units)
Figure Europe Hemophillia A and B Therapeutics Materials Revenue Forecast 2018-2025 (Million US$)
Table China Hemophillia A and B Therapeutics Materials Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure China Hemophillia A and B Therapeutics Materials Production Forecast 2018-2025 (K Units)
Figure China Hemophillia A and B Therapeutics Materials Revenue Forecast 2018-2025 (Million US$)
Table Japan Hemophillia A and B Therapeutics Materials Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure Japan Hemophillia A and B Therapeutics Materials Production Forecast 2018-2025 (K Units)
Figure Japan Hemophillia A and B Therapeutics Materials Revenue Forecast 2018-2025 (Million US$)
Table Global Hemophillia A and B Therapeutics Materials Production Forecast by Type 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Production Forecast by Type 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Production Market Share Forecast by Type 2018-2025
Table Global Hemophillia A and B Therapeutics Materials Production Value Forecast by Type 2018-2025 (Million US$)
Figure Global Hemophillia A and B Therapeutics Materials Production Value Forecast by Type 2018-2025 (Million US$)
Figure Global Hemophillia A and B Therapeutics Materials Production Value Market Share Forecast by Type 2018-2025
Table Global Hemophillia A and B Therapeutics Materials Consumption Forecast by Application 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Consumption Forecast by Application 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Consumption Market Share Forecast by Application 2018-2025
Table Global Hemophillia A and B Therapeutics Materials Consumption Forecast by Regions 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Consumption Forecast by Regions 2018-2025 (K Units)
Figure Global Hemophillia A and B Therapeutics Materials Consumption Market Share Forecast by Regions 2018-2025
Table North America Hemophillia A and B Therapeutics Materials Consumption Forecast by Regions 2018-2025 (K Units)
Figure United States Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Canada Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure MexicoHemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Table Europe Hemophillia A and B Therapeutics Materials Consumption Forecast by Regions 2018-2025 (K Units)
Figure Germany Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure France Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure UK Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Italy Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Russia Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Table Asia Pacific Hemophillia A and B Therapeutics Materials Consumption Forecast by Regions 2018-2025 (K Units)
Figure China Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Japan Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Korea Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure India Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Australia Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Indonesia Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Thailand Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Malaysia Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Philippines Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure Vietnam Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Table Central & South America Hemophillia A and B Therapeutics Materials Consumption Forecast by Regions 2018-2025 (K Units)
Figure Brazil Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Table Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption Forecast by Regions 2018-2025 (K Units)
Figure Middle East and Africa Hemophillia A and B Therapeutics Materials Consumption Forecast 2018-2025 (K Units)
Figure GCC Countries Hemophillia A and B Therapeutics Materials Sales Growth Rate (2018-2025) (K Units)
Figure Egypt Hemophillia A and B Therapeutics Materials Sales Growth Rate (2018-2025) (K Units)
Figure South Africa Hemophillia A and B Therapeutics Materials Sales Growth Rate (2018-2025) (K Units)
Figure Hemophillia A and B Therapeutics Materials Value Chain
Table Hemophillia A and B Therapeutics Materials Distributors List
Table Hemophillia A and B Therapeutics Materials Customers List
Table Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Arsia therapeutics、Spark Therapeutics, Inc.、Alnylam Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.

★調査レポート[血友病A&B治療機器の世界市場動向・分析2018-2025] (コード:QYR8D04721)販売に関する免責事項を必ずご確認ください。
★調査レポート[血友病A&B治療機器の世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆